nitrofurantoin antibacterial medication used treat urinary tract infections effective kidney taken common side effects include nausea loss appetite diarrhea rarely numbness lung problems liver problems may used people kidney appears generally safe pregnancy used near usually works slowing bacterial growth may result bacterial death high concentrations found nitrofurantoin first sold world health organizations list essential available generic commonly prescribed medication united states million current uses include treatment uncomplicated urinary tract infections utis prophylaxis utis people prone recurrent increasing bacterial antibiotic resistance commonly used agents trimethoprimsulfamethoxazole fluoroquinolones led increased interest using efficacy nitrofurantoin treating utis combined low rate bacterial resistance agent makes one firstline agents treating uncomplicated utis recommended infectious diseases society america european society microbiology infectious nitrofurantoin recommended treatment intraabdominal extremely poor tissue penetration low blood levels nitrofurantoin shown good activity againstcitation needed used treatment infections caused many strains following genera resistant antibiotic susceptibility testing always performed elucidate resistance profile particular strain bacteria causing infectioncitation needed nitrofurantoin pregnancy category b united states pregnancy category one drugs commonly used pregnancy treat however used late pregnancy due potential risk hemolytic anemia newborns women given drug late pregnancy higher risk developing neonatal evidence safety early pregnancy mixed american college obstetricians gynecologists states used first trimester options may remain first line treatment second meta analysis found increased risk first trimester use cohort studies slight increase malformations case control two formulations nitrofurantoin nitrofurantoin contraindicated patients decreased renal function crcl mlmin due systemic accumulation subtherapeutic levels reached urinary however retrospective chart review suggests data cutoff slim cutoff crcl mlmin would many severe side effects drug common elderly renal impairment causes drug retained body reach higher systemic levels thus drug recommended elderly population according ags beers nitrofurantoin also contraindicated babies age one month immature enzyme systems red blood cells glutathione instability nitrofurantoin must used cause haemolytic anaemia reason nitrofurantoin given pregnant women weeks pregnancy nitrofurantoin contraindicated patients dehydrogenase deficiency risk intravascular hemolysis resulting common side effects nitrofurantoin nausea headache flatulence less common adverse events occurring less taking drug patients informed nitrofurantoin colors urine brown completely serious rare side effects nitrofurantoin cause concern include pulmonary reactions hepatotoxicity neuropathy pulmonary toxicity caused nitrofurantoin categorized acute subacute chronic pulmonary reactions acute subacute reactions thought due hypersensitivity reaction often resolve drug discontinued acute reactions estimated occur one women take reactions usually develop days first dose nitrofurantoin may occur hours weeks starting drug symptoms include fever dyspnea chills cough pleuritic chest pain headache back pain epigastric pain chest radiograph often show unilateral bilateral infiltrates similar pulmonary edema treatment includes discontinuation nitrofurantoin result symptom improvement within chronic pulmonary reactions caused nitrofurantoin include diffuse interstitial pneumonitis pulmonary fibrosis uncommon reaction may occur month years starting drug usually related total lifetime dosecitation needed reaction manifests progressive shortness important recognize nitrofurantoin possible cause symptoms discontinue drug suspicion pulmonary side effects arises reversible drug stopped hepatic reactions including hepatitis cholestatic jaundice chronic active hepatitis hepatic necrosis occur rarely onset chronic active hepatitis may insidious patients monitored periodically changes biochemical tests would indicate liver reactions usually occur exposure drug weeks signs liver failure observed patient taking nitrofurantoin drug discontinued rechallenge drug later date recommended reaction may hypersensitivity component recur drug neuropathy rare side effect taking nitrofurantoin patients may experience numbness tingling stockingglove pattern may may improve upon discontinuation organisms said susceptible nitrofurantoin minimum inhibitory concentration μgml less peak blood concentration nitrofurantoin following oral dose nitrofurantoin mg less μgml may undetectable bioavailability urinary excretion tissue penetration negligible drug well concentrated urine dose rapidly metabolised liver dose excreted urine unchanged reliably achieving levels μgml studies dogs majority urinary excretion glomerular filtration tubular also tubular absorption increased urine however activity nitrofurantoin also ph dependent mean inhibitory concentration rises sharply increased ph nitrofurantoin used treat infections simple cystitis concentrations achieved urine μgml nitrofurantoin bactericide bacteriostatic susceptible organisms concentrations less nitrofurantoin quinolone antibiotics mutually antagonistic vitro known whether clinical significance combination resistance nitrofurantoin may chromosomal plasmidmediated involves inhibition nitrofuran acquired resistance e coli continues rare nitrofurantoin metabolites excreted mainly kidneys renal impairment concentration achieved urine may subtherapeutic nitrofurantoin used patients creatinine clearance mlmin less however retrospective chart review may suggest nitrofurantoin contraindicated nitrofurantoin concentrated urine leading higher effective levels urinary tract tissues mg oral dose plasma levels typically less µgml urine reaches drug works damaging bacterial dna since reduced form highly made possible rapid reduction nitrofurantoin inside bacterial cell flavoproteins nitrofuran reductase multiple reactive intermediates attack ribosomal proteins respiration pyruvate metabolism macromolecules within cell nitrofurantoin exerts greater effects bacterial cells mammalian cells bacterial cells activate drug rapidly known actions nitrofurantoin primarily responsible bactericidal activity broad mechanism action drug likely responsible low development resistance effects drug affects many different processes important bacterial nitrofurantoin available treatment lower urinary tract infections utis since nitrofurantoin marketed many names countries residues breakdown nitrofuran veterinary antibiotics including nitrofurantoin found chicken vietnam china brazil european union banned use nitrofurans food producing animals classifying annex iv list pharmacologically active substances maximum residue limits fixed council regulation food drug administration fda united states prohibited furaltadone since february withdrew approval nitrofuran drugs except topical uses january topical use furazolidone nitrofurazone prohibited australia prohibited use nitrofurans food production japan allocate mrls nitrofurans leading implementation zero tolerance residue standard thailand ministry health issued proclamation mrl veterinary drug food allocate mrl nitrofurans ministry agriculture cooperatives already prohibited importation use furazolidone nitrofurazone animal feed extended nitrofurans several metabolites nitrofurans furazolidone furaltadone nitrofurazone cause cancer genetic damage httpsenwikipediaorgwikinitrofurantoin